After the stress of the past two years, 2022 felt like we were starting back into the world again. Despite ongoing pandemic pressures at work and home, we came together as a community this year to advance science and make a difference for patients. We have so much to celebrate — our first in-person annual...
Study finds people with diabetes who fast intermittently may no longer need medication After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society’s Journal of Clinical...
New study leverages Fitbit data to show benefits of active lifestyle on diabetes risk Wearable fitness devices offer new insights into the relationship between physical activity and type 2 diabetes, according to a new analysis of the National Institutes of Health’s All of Us Research Program data published in the Endocrine Society’s Journal of Clinical Endocrinology...
The Endocrine Society advocates on behalf of our members, the patients they treat, and the science they research. This year, in addition to continuing our virtual advocacy, we had the opportunity to reintroduce several in-person advocacy activities. With help from our members, we successfully advocated for our policy priorities and raised awareness of the value...
Dexcom announced recently that the FDA has cleared its next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all types of diabetes ages two years and older. Dexcom says it is working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as...
People with diabetes are benefiting from advances in medications and technologies to lower their risk of hypoglycemia, according to a Clinical Practice Guideline issued today by the Endocrine Society. The guideline, titled “Management of Individuals with Diabetes at High Risk for Hypoglycemia: An Endocrine Society Clinical Practice Guideline,” was published online and will appear in the March 2023 print...
Scientists from the University of Nottingham have discovered that the novel insulin-like peptide hormone INSL3 is consistent over long periods of time and is an important early biomarker for prediction of age-linked disease and published their findings in Frontiers in Endocrinology. Researchers led by Richard Ivell, PhD, and Ravinder Anand-Ivell, PhD, FRSB, point out that...
Each year, the Center for Medicare and Medicaid Services (CMS) releases the Medicare Physician Fee Schedule (MPFS) rule, which outlines the agency’s payment and quality program policies for the upcoming year. Medicare policy often sets the bar for the private insurance market as well. Therefore, the payment policies and other revisions in the MPFS are...
After the stress of the past two years, 2022 felt like we were starting back into the world again. Despite ongoing pandemic pressures at work and home, we came together as a community this year to advance science and make a difference for patients. We have so much to celebrate — our first in-person annual...
